State Of New Jersey Common Pension Fund D Kodiak Sciences Inc. Transaction History

State Of New Jersey Common Pension Fund D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$5.04 - $9.48 $252,967 - $475,820	-50,192 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$7.09 - $89.45 $154,023 - $1.94 Million	21,724 Added 76.31%	50,192 $387,000
Q4 2021 Jan 31, 2022	SELL	$80.85 - $128.49 $114,564 - $182,070	-1,417 Reduced 4.74%	28,468 $2.41 Million
Q3 2021 Oct 27, 2021	SELL	$81.97 - $106.94 $14,098 - $18,393	-172 Reduced 0.57%	29,885 $2.87 Million
Q2 2021 Jul 23, 2021	BUY	$77.2 - $126.54 $727,996 - $1.19 Million	9,430 Added 45.72%	30,057 $2.8 Million
Q1 2021 Apr 27, 2021	SELL	$110.45 - $164.47 $769,394 - $1.15 Million	-6,966 Reduced 25.25%	20,627 $2.34 Million
Q4 2020 Feb 03, 2021	BUY	$60.78 - $154.03 $1.68 Million - $4.25 Million	27,593 New	27,593 $4.05 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $373M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.